NO996514L - Overflateantigener og proteiner nyttige i sammensetninger for diagnose og forebygging av Lymesykdom - Google Patents

Overflateantigener og proteiner nyttige i sammensetninger for diagnose og forebygging av Lymesykdom

Info

Publication number
NO996514L
NO996514L NO996514A NO996514A NO996514L NO 996514 L NO996514 L NO 996514L NO 996514 A NO996514 A NO 996514A NO 996514 A NO996514 A NO 996514A NO 996514 L NO996514 L NO 996514L
Authority
NO
Norway
Prior art keywords
diagnosis
lyme disease
prevention
compositions
surface antigens
Prior art date
Application number
NO996514A
Other languages
English (en)
Other versions
NO996514D0 (no
Inventor
Mario T Philipp
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Publication of NO996514D0 publication Critical patent/NO996514D0/no
Publication of NO996514L publication Critical patent/NO996514L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Et nytt isoler Borrelia burgdorferi sensu lato overflateantigen er karakterisert med en relativ molekylmasse på 39,5 kDa. Dette antigenet blir uttrykt in vitro av spirocheter fra en B. burgdorferi sensu lato stamme. Dette antigenet induserer antistoffer som avliver spirocheter fra en B. burgdorferi sensu lato stamme med ADCK in vitro. Nytt Borrelia kassettstrengprotein eller fragmenter derav er også nyttige, det er også P39.5 protein i diagnostisering av Lyme sykdom og i sammensetning for behandling av profylakse derav.
NO996514A 1997-06-30 1999-12-28 Overflateantigener og proteiner nyttige i sammensetninger for diagnose og forebygging av Lymesykdom NO996514L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5127197P 1997-06-30 1997-06-30
PCT/US1998/013551 WO1999000413A1 (en) 1997-06-30 1998-06-29 Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease

Publications (2)

Publication Number Publication Date
NO996514D0 NO996514D0 (no) 1999-12-28
NO996514L true NO996514L (no) 2000-02-14

Family

ID=21970280

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996514A NO996514L (no) 1997-06-30 1999-12-28 Overflateantigener og proteiner nyttige i sammensetninger for diagnose og forebygging av Lymesykdom

Country Status (17)

Country Link
US (2) US6660274B2 (no)
EP (1) EP1012181B1 (no)
JP (1) JP2002511760A (no)
KR (1) KR20010020567A (no)
CN (1) CN1261896A (no)
AR (1) AR016295A1 (no)
AT (1) ATE337335T1 (no)
AU (1) AU8177298A (no)
CA (1) CA2294701C (no)
CO (1) CO4790101A1 (no)
DE (1) DE69835682T2 (no)
DK (1) DK1012181T3 (no)
ES (1) ES2270523T3 (no)
NO (1) NO996514L (no)
PL (1) PL337667A1 (no)
WO (1) WO1999000413A1 (no)
ZA (1) ZA985704B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69733944T3 (de) * 1996-02-21 2012-07-26 The Board Of Regents, The University Of Texas System Vmp-ähnliche sequenzen von pathogener borrelia
WO1999000413A1 (en) * 1997-06-30 1999-01-07 The Administrators Of The Tulane Educational Fund Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
US6475492B1 (en) * 1999-04-28 2002-11-05 The Administrators Of The Tulane Educational Fund Peptides and assays for the diagnosis of lyme disease
AU2003299872A1 (en) 2002-12-20 2004-07-22 Board Of Regents, The University Of Texas System Vmp-like sequences of pathogenic borrelia species and strains
WO2007133623A2 (en) * 2006-05-10 2007-11-22 Biopeptides Corporation Peptide diagnostic agent for lyme disease
MX2009004866A (es) 2006-11-03 2009-05-19 Schering Plough Ltd Vacuna para enfermedad de lyme canina.
ES2337113B1 (es) * 2007-04-17 2011-01-24 Centre De Recerca En Sanitat Animal (Cresa) Empleo de la hemaglutinina del virus de la peste porcina africana como adyuvante.
WO2009033163A2 (en) * 2007-09-07 2009-03-12 The Regents Of The University Of California Borrelia diagnostics and screening methods
WO2010132758A2 (en) * 2009-05-14 2010-11-18 Gomes-Solecki Maria J Ospc-based diagnostic test for lyme disease
EP2501719B1 (en) * 2009-11-17 2015-11-04 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
US8623375B2 (en) * 2010-05-14 2014-01-07 Baxter International Inc. Chimeric OspA genes, proteins, and methods of use thereof
WO2012047607A2 (en) 2010-09-27 2012-04-12 Cornell University Methods for diagnosing lyme disease
WO2013067448A2 (en) 2011-11-03 2013-05-10 Vca Antech Inc. Compositions and methods to detect various infectious organisms
US8758772B2 (en) 2011-11-04 2014-06-24 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
US9670537B2 (en) 2014-06-06 2017-06-06 Titan Collaborative Kithe, Llc Borrelia Provocation Procedure kit
US11061028B2 (en) 2014-09-24 2021-07-13 Defined Diagnostics, Llc Compositions and methods for the diagnosis of lyme disease
AU2016311441B2 (en) 2015-08-27 2023-06-01 Ortho-Clinical Diagnostics, Inc. Immunoassay test device with two fluid flow paths for detection and differentiation of two or more analytes
EP4071477B1 (en) * 2015-09-25 2026-01-21 QIAGEN Sciences, LLC Compositions and methods for diagnosing lyme disease and for predicting lyme disease spirochete elimination after treatment
CN106397589A (zh) * 2016-10-31 2017-02-15 杭州贝英福生物科技有限公司 一种狭义伯氏疏螺旋体多克隆抗体及应用
CN106432487A (zh) * 2016-10-31 2017-02-22 杭州贝英福生物科技有限公司 一种伽氏疏螺旋体多克隆抗体及应用
CA3053110A1 (en) 2017-02-10 2018-08-16 Quidel Corporation Lateral flow assay with substrate having channels for controlled fluid flow
CN109596824A (zh) * 2019-01-04 2019-04-09 杭州奥泰生物技术股份有限公司 一种快速诊断莱姆病的检测试纸及其制备方法
WO2025049353A1 (en) 2023-08-25 2025-03-06 Focus on Lyme Foundation Multi-antigen diagnostic for detecting lyme disease

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US485551A (en) 1892-11-01 And william
DK590288D0 (da) 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
EP0339695A3 (en) 1988-04-29 1990-05-30 Stichting Voor De Technische Wetenschappen A process for preparing an antigenic or immunogenic conjugate as well as the use of such conjugates
ES2092560T5 (es) 1989-12-22 2004-09-16 Mikrogen Molekularbiologische Entwicklungs-Gmbh Proteinas inmunologicamente activas de borrelia burgdorferi, estuches de ensayo relacionados y vacuna.
US5217872A (en) * 1990-02-27 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Method for detection of borrelia burgdorferi antigens
WO1991013630A1 (en) 1990-03-05 1991-09-19 The United States Of America, Represented By The Secretary, United States Department Of Commerce ANTIGENIC PROTEINS OF $i(BORRELIA BURGDORFERI)
SG122738A1 (en) 1990-06-15 2006-06-29 Univ Yale Compositions and methods for the prevention and diagnosis of lyme disease
IE912303A1 (en) 1990-07-06 1992-01-15 American Home Prod Vaccine against lyme disease and a challenge model for¹evaluating vaccine efficiency
DE69733944T3 (de) * 1996-02-21 2012-07-26 The Board Of Regents, The University Of Texas System Vmp-ähnliche sequenzen von pathogener borrelia
DE19632862B4 (de) * 1996-08-14 2006-08-03 Mikrogen Molekularbiologische Entwicklungs-Gmbh Immunologisch aktive Proteine von Borrelia burgdorferi, dafür kodierende Nukleinsäuren sowie deren Verwendung in Testkits und als Impfstoffe
WO1999000413A1 (en) * 1997-06-30 1999-01-07 The Administrators Of The Tulane Educational Fund Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
US6475492B1 (en) * 1999-04-28 2002-11-05 The Administrators Of The Tulane Educational Fund Peptides and assays for the diagnosis of lyme disease

Also Published As

Publication number Publication date
US20040067517A1 (en) 2004-04-08
CA2294701A1 (en) 1999-01-07
DE69835682T2 (de) 2007-08-23
ES2270523T3 (es) 2007-04-01
ATE337335T1 (de) 2006-09-15
CA2294701C (en) 2009-09-08
NO996514D0 (no) 1999-12-28
EP1012181A1 (en) 2000-06-28
EP1012181B1 (en) 2006-08-23
AR016295A1 (es) 2001-07-04
KR20010020567A (ko) 2001-03-15
ZA985704B (en) 1999-01-13
US20030059894A1 (en) 2003-03-27
CN1261896A (zh) 2000-08-02
DK1012181T3 (da) 2007-01-02
PL337667A1 (en) 2000-08-28
AU8177298A (en) 1999-01-19
JP2002511760A (ja) 2002-04-16
CO4790101A1 (es) 1999-05-31
DE69835682D1 (de) 2006-10-05
WO1999000413A1 (en) 1999-01-07
US6660274B2 (en) 2003-12-09

Similar Documents

Publication Publication Date Title
CA2294701A1 (en) Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
BR9714160A (pt) Antìgenos uspa1 e uspa2 de moraxella catarrhalis
CY1117387T1 (el) ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ Ν-11 ΔΙΑΣΠΑΣΜΕΝΟΥ β-ΑΜΥΛΟΕΙΔΟΥΣ, ΣΥΝΘΕΣΕΙΣ, ΜΕΘΟΔΟΙ ΚΑΙ ΧΡΗΣΕΙΣ
WO2005056600A3 (en) Monoclonal antibodies that bind or neutralize dengue virus
DE69637914D1 (de) Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus
SE0103754L (sv) Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
WO2000077216A3 (en) Porcine circovirus vaccine in recombinant poxvirus
BR9610872A (pt) Proteìna receptora de transferrina de moraxella
EP1731166A3 (en) Streptococcus pneumoniae proteins and vaccines
ATE453403T1 (de) Wirtszelle enthaltend ein rekombinantes virus, welches ein antigen exprimiert und ein rekombinantes virus, welches ein immunstimulatorisches molekül exprimiert
AU2003217055A1 (en) Protein for use in hypoxia related conditions
AU2001276619A1 (en) Immunisation against chlamydia pneumoniae
EP0683234A4 (en) ANTIBODIES DIRECTED AGAINST -g (b) -AMYLOID OR A DERIVATIVE THEREOF AND ITS USE.
EP0090581A3 (en) Small peptides with the specificity of foot and mouth disease viral antigens
ATE375391T1 (de) Chlamydia-antigene und entsprechende dna- fragmente und deren verwendungen
CA2235224A1 (en) Diagnostics and treatments of periodontal disease
NO331277B1 (no) Farmasoytisk sammensetning omfattende polypetid/nukleinsyre for behandling av retinale degenererende sykdommer, vektor, isolert polypeptid, renset antistoff og anvendelse av polypeptid, nukleinsyre og antistoff, samt fremgangsmater og kit
UA42040C2 (uk) Поліпептид, спосіб діагностики інсулінозалежного цукрового діабету (iddm), що розвинувся або що розвивається (варіанти), набір для діагностики iddm (варіанти), препарат для запобігання або лікування iddm, фармацевтична композиція для профілактики або лікування iddm
DE69737323D1 (de) Adhesin aus heliobacter pylori, welches an blutgruppenantigene bindet
ATE142888T1 (de) Antigen-wirkende proteine von borrelia burgdorferi
AU2002310474A1 (en) Multiple antigenic peptide displaying multiple copies of an epitope of plaque-forming polypeptide and methods of using same
BR0207528A (pt) Anticorpo, composição farmacêutica, e, usos de uma quantidade efetiva de um agente, de uma quantidade terapeuticamente efetiva de um anticorpo para il-22, de uma quantidade imunogênica do antìgeno e uma quantidade aumentadora de imunogenicidade de il-22 em combinação, de uma quantidade efetiva do anticorpo ou fragmento do mesmo e de uma quantidade suficiente de anticorpo ou fragmento ligado a antìgeno do mesmo
DE69233311D1 (de) Weidelgraspollen-allergen
ATE398137T1 (de) Porphyromonas gingivalis antigene zur diagnose und behandlung von periodontitis
PT868522E (pt) Virus recombinante de poxvirus - virus da peritonite infecciosa felina, suas composicoes e metodos para a sua preparacao e utilizacao

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application